Sir, We thank Dr Joob and Dr Wiwanitkit for their valuable comments on our work.
This study was carried out at the height of the Swine flu Pandemic situation in Pune,India. The indigenous nasal Bubble CPAP was invented because it was the need of time and our initial results show that it is effective. This effectiveness under pandemic situation was the reason we could not conduct a randomized control trial, wherein costeffectiveness analysis would have been a secondary outcome. However, we would like to share that the cost of commercially available bubble CPAP unit is approximately 3 lakh rupees, while the assembled indigenous circuit made from readily available material in any hospital costs only 200 rupees. It would be ideal to have a randomized control trial comparing the safety and efficacy of indigenous bubble CPAP versus commercially available bubble CPAP.
The circuits are used for individual patients and discarded after use. All infection control practices were meticulously adhered to while caring for children admitted to the isolation ward. The circuits are also being used till date routinely in our NICU and PICU without any nosocomial infection outbreaks.
